display ongoing
results: demonstrated suggested inconclusive safety concern ongoing study
locally advanced NSCLC - (neo)adjuvant (NA)metastatic/advanced NSCLC (mNSCLC) - 1st line (L1)metastatic/advanced NSCLC (mNSCLC) - 2nd line (L2)NSCLC neoadjuvant setting
locally advanced NSCLC - (neo)adjuvant (NA)mNSCLC - L1 - PDL1 negativemNSCLC - L1 - PDL1 positivemNSCLC - L2 - all populationnon squamous - mNSCLC - L2 - all populationsquamous - mNSCLC - L2 - all populationNSCLC neoadjuvant setting
nivolumab based treatment
nivolumab alone CheckMate 026 ... CheckMate 026 ... CheckMate 078 CheckMate 057 CheckMate 017
nivolumab plus SoC CheckMate 816 CheckMate 227 ... CheckMate 816

Study type:

 

- About us - Contact us - Method - RSS Made with in Lyon - Credits - Privacy policy - Licence Creative Commons